A detailed history of Prudential Financial Inc transactions in Ocugen, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 23,910 shares of OCGN stock, worth $23,910. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,910
Previous 44,310 46.04%
Holding current value
$23,910
Previous $68,000 66.18%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$0.98 - $1.95 $19,992 - $39,780
-20,400 Reduced 46.04%
23,910 $23,000
Q2 2024

Aug 13, 2024

BUY
$1.18 - $1.98 $52,285 - $87,733
44,310 New
44,310 $68,000
Q2 2022

Aug 15, 2022

BUY
$1.83 - $3.45 $2,232 - $4,209
1,220 Added 8.7%
15,235 $35,000
Q4 2021

Feb 14, 2022

SELL
$4.38 - $15.67 $2,781 - $9,950
-635 Reduced 4.33%
14,015 $64,000
Q3 2021

Nov 15, 2021

BUY
$6.36 - $8.51 $1,272 - $1,702
200 Added 1.38%
14,650 $105,000
Q2 2021

Aug 16, 2021

BUY
$5.52 - $15.68 $79,764 - $226,576
14,450 New
14,450 $116,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $217M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.